(2R,3R)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydro-9H-[1,4]dioxino[2,3-h]chromen-9-one(CAS: 84575-10-0)

This compound is subject to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for classification and labeling. It must comply with the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation in the European Union. In the United States, the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) may also have specific requirements for handling and storage. Always consult the latest regulatory guidelines and safety data sheets for detailed information.

Alternatives to this compound in synthesis may include other chromones or related dioxepines with similar functional groups. Commonly used alternatives include 7-hydroxy-4H-chromen-4-one, 3,4-dihydro-2H-dioxepin-2-one, and their isomers. Other substitutes may depend on the specific application and desired properties.

The market for this compound is primarily driven by its use in pharmaceuticals, specifically as an intermediate in the synthesis of various bioactive molecules. Research trends indicate an increasing focus on developing compounds with enhanced biological activity and improved pharmacokinetic properties. Market trends suggest steady demand, with potential growth in specialized applications.

Waste containing this compound should be collected in appropriate, labeled containers and stored according to local regulations. Incineration is a common method for disposal, but it must be conducted in a controlled incinerator to minimize environmental impact. Professional waste disposal services are recommended for safe and compliant handling. Ensure proper protective measures are taken during handling to prevent exposure and environmental contamination.